Inhibition of a G9a/DNMT network triggers an immune-mediated bladder cancer regression treated with CM272 (IC50). Inhibition of a G9a/DNMT network triggers an immune-mediated bladder cancer regression treated with CM272 (IC50)
收藏NIAID Data Ecosystem2026-03-10 收录
官方服务：
资源简介：
Based on the identification of G9a as a potential target in BC, we decided to test the effect of a recently described dual inhibitor against G9a/DNMTs, CM-272, in several BC cell lines Overall design: Gene expression was compared between bladder cancer cell lines with the same cell lines treated with CM272 (IC50)
创建时间：
2018-06-08
